Literature DB >> 30471902

Expression patterns of hepatic genes involved in lipid metabolism in cows with subclinical or clinical ketosis.

Yiwei Zhu1, Guowen Liu1, Xiliang Du1, Zhen Shi1, Meiyu Jin1, Xueying Sha1, Xiaobing Li1, Zhe Wang1, Xinwei Li2.   

Abstract

Dairy cows with ketosis are characterized by high blood concentrations of ketone bodies and hepatic lipid metabolism disorder. The discrepancies in the abundance of mRNA encoding a variety of hepatic candidate genes in varying degrees of ketotic cows represent specific responses of the liver to the challenge of fatty acids and ketone bodies. Importantly, the expression disorder of hepatic genes involved in lipid metabolism plays a promoting role in the onset and progression of ketosis. Thus, the aim of this study was to investigate the expression patterns of genes involved in the hepatic fatty acids uptake, transport, activation, β-oxidation, synthesis, and esterification in the cows with subclinical ketosis (SCK) or clinical ketosis (CK). Twenty-four cows were selected into control [n = 8, β-hydroxybutyrate (BHB) ≤0.6 mM], SCK (n = 8, 3.0 > BHB ≥ 1.2 mM), and CK (n = 8, BHB ≥3.0 mM) groups according to the blood BHB concentration and clinical symptoms. The accumulation of hepatic lipid, as indicated by triglycerides (TG) contents and Oil Red O and hematoxylin and eosin staining, was pronouncedly exacerbated in the tCK group compared with the control and SCK groups. The hepatic mRNA expression of fatty acids transport and activation genes, liver fatty acid-binding protein (FABP1) and long-chain acyl-CoA synthetase 1 (ACSL1), were both significantly higher in the SCK and CK groups than in the control group. The expression levels of peroxisome proliferator-activated receptor α (PPARA) and its target genes, carnitine palmitoyltransferase 1A (CPT1A) and carnitine palmitoyltransferase 2 (CPT2), were significantly elevated in the SCK group but reduced in the CK group compared with control group. Furthermore, the gene expression level of sterol regulatory element-binding protein 1 (SREBP1) and the protein expression level of sterol regulatory element-binding protein 1c and its target genes acetyl-CoA carboxylase 1 (ACC1), fatty acid synthase (FAS), and stearoyl-CoA desaturase-1 (SCD1) and TG synthesis genes diacylglycerol acyltransferase 1 (DGAT1) and diacylglycerol acyltransferase 2 (DGAT2) were significantly higher in the CK group relative to the control group. In short, the present data indicated that hepatic fatty acids uptake, transport, and activation are significantly increased in cows with SCK and CK, hepatic fatty acids β-oxidation is significantly increased in SCK cows but markedly decreased in CK cows, and hepatic fatty acids and TG synthesis are significantly increased in CK cows, thereby inducing hepatic steatosis in CK cows.
Copyright © 2019 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fatty acids; ketosis; lipid metabolism; liver

Mesh:

Substances:

Year:  2018        PMID: 30471902     DOI: 10.3168/jds.2018-14965

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  12 in total

1.  Reduction of oocyte lipid droplets and meiotic failure due to biotin deficiency was not rescued by restoring the biotin nutritional status.

Authors:  Ai Tsuji; Yuka Ikeda; Mutsumi Murakami; Yasuko Kitagishi; Satoru Matsuda
Journal:  Nutr Res Pract       Date:  2021-10-12       Impact factor: 1.992

2.  Ufbp1, a Key Player of Ufm1 Conjugation System, Protects Against Ketosis-Induced Liver Injury via Suppressing Smad3 Activation.

Authors:  Fanghui Chen; Le Sheng; Chenjie Xu; Jun Li; Ilyas Ali; Honglin Li; Yafei Cai
Journal:  Front Cell Dev Biol       Date:  2021-07-08

3.  Intracellular Ca2+ signaling and ORAI calcium release-activated calcium modulator 1 are associated with hepatic lipidosis in dairy cattle.

Authors:  Ming Li; Wei Yang; Jianan Wen; Juan J Loor; Ahmad Aboragah; Jingjing Wang; Shuang Wang; Mingyang Li; Liyun Yu; Xilin Hou; Chuang Xu; Bingbing Zhang
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.338

4.  Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways.

Authors:  Bingyu Shen; Chenxu Zhao; Yue Wang; Yi Peng; Jiaqi Cheng; Zheng Li; Lin Wu; Meiyu Jin; Haihua Feng
Journal:  J Cell Mol Med       Date:  2019-04-04       Impact factor: 5.310

5.  Protective effect of selenomethionine on T-2 toxin-induced liver injury in New Zealand rabbits.

Authors:  Yumei Liu; Haojie Wang; Mengyu Zhang; Jiajia Wang; Zhixiang Zhang; Yuqin Wang; Yingying Sun; Ziqiang Zhang
Journal:  BMC Vet Res       Date:  2021-04-09       Impact factor: 2.741

6.  The Role of Tea Tree Oil in Alleviating Palmitic Acid-Induced Lipid Accumulation in Bovine Hepatocytes.

Authors:  Tianyu Yang; Xiaoyu Ma; Maocheng Jiang; Zhiqiang Cheng; Osmond Datsomor; Guoqi Zhao; Kang Zhan
Journal:  Front Vet Sci       Date:  2022-01-21

7.  Differentiation of Subclinical Ketosis and Liver Function Test Indices in Adipose Tissues Associated With Hyperketonemia in Postpartum Dairy Cattle.

Authors:  Muhammad Ali Mohsin; Huiru Yu; Rongze He; Peng Wang; Linli Gan; Yulan Du; Yunfei Huang; Muhammad Bakhsh Abro; Sarmad Sohaib; Mariusz Pierzchala; Przemysław Sobiech; Klaudia Miętkiewska; Chandra S Pareek; Bao Xiang He
Journal:  Front Vet Sci       Date:  2022-02-03

8.  The Bovine Hepatic Cell Line BFH12 as a Possible Model for Hepatosteatosis in Dairy Cows.

Authors:  Kristin Reichelt; Anna M Niebisch; Johannes Kacza; Axel Schoeniger; Herbert Fuhrmann
Journal:  Front Vet Sci       Date:  2022-03-11

9.  Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management.

Authors:  Khuram Shahzad; Vincenzo Lopreiato; Yusheng Liang; Erminio Trevisi; Johan S Osorio; Chuang Xu; Juan J Loor
Journal:  J Anim Sci Biotechnol       Date:  2019-12-18

10.  ACSL1 affects Triglyceride Levels through the PPARγ Pathway.

Authors:  Tingting Li; Xiangdong Li; Heyu Meng; Lili Chen; Fanbo Meng
Journal:  Int J Med Sci       Date:  2020-02-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.